University of Southern Denmark (SDU)
This sponsor has funded 4 studies across 1 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 34734 | Ongoing | Use of non-steroidal anti-inflammatory drugs and clinical outcome of COVID-19: a Danish nationwide cohort study (NSAID COVID-19) | Yes | No |
| 36056 | Ongoing | The prognosis of coronavirus disease (COVID-19) in patients recently treated with immunosuppressant medications. | Yes | No |
| 36804 | Finalised | Risk and course of COVID-19 infection in patients with hypo- or hyperthyroidism. A Danish population-based cohort study (Thyroid dysfunction and... | Yes | Yes |
| 37658 | Finalised | Dynamics of prescription drug use, diagnoses and health care utilization after community managed SARS-CoV-2 infection | Yes | No |
PAS by Risk Management Plan (RMP) requirement
University of Southern Denmark (SDU)
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
University of Southern Denmark (SDU)
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
University of Southern Denmark (SDU)
1 Study countries specified are the following:
- Denmark